135987 20260217205547.0 doi 10.1016/j.cmi.2024.04.017 sideral 138990 ART-2024-138990 eng Rabodoarivelo, Marie Sylvianne Universidad de Zaragoza Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method 2024 Access copy available to the general public Unrestricted info:eu-repo/semantics/openAccess by-nc-nd https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es 8.5 2024 MICROBIOLOGY 14 / 163 = 0.086 2024 Q1 T1 INFECTIOUS DISEASES 5 / 137 = 0.036 2024 Q1 T1 2.742 2024 Infectious Diseases 2024 Q1 Microbiology (medical) 2024 Q1 Medicine (miscellaneous) 2024 Q1 22.4 2024 info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion Gómez, Ana Belén Universidad de Zaragoza (orcid)0000-0002-9713-2127 Picó Marco, Ana Universidad de Zaragoza (orcid)0000-0003-4409-1437 Martín, Carlos Universidad de Zaragoza (orcid)0000-0003-2993-5478 Ramón-García, Santiago (orcid)0000-0002-8480-0325 1011 630 Universidad de Zaragoza Dpto. Microb.Ped.Radio.Sal.Pú. Área Microbiología 1011 X Universidad de Zaragoza Dpto. Microb.Ped.Radio.Sal.Pú. Proy. investigación HQA 30, 8 (2024), 1080-1082 Clin. microbiol. infect. Clinical Microbiology and Infection 1198-743X 305631 http://zaguan.unizar.es/record/135987/files/texto_completo.pdf Postprint 947284 http://zaguan.unizar.es/record/135987/files/texto_completo.jpg?subformat=icon icon Postprint oai:zaguan.unizar.es:135987 articulos driver 2026-02-17-20:38:33 ARTICLE